Bruker Corp (BRKR)

Common Shares
Sell: $36.65|Buy: $37.23|Change: 1.22 (-3.19%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

Open 

$37.97


Previous close 

$38.20


Trade high 

$38.63


Volume 

2,473,882


Year high 

$64.64


Year low 

$28.53


Dividend yield 

0.54%


Market capitalisation 

$5.61 bn


P/E ratio 

71.12


ISIN 

US1167941087


Share price

Dividends

PreviousLatest
Record date16/06/202523/09/2025
Ex-dividend date16/06/202523/09/2025
Payment date27/06/202503/10/2025
Amount$0.05$0.05

Performance 17/10/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Bruker Corp- 3.19
More...

Company profile

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments(BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.